16
Participants
Start Date
August 31, 2010
Primary Completion Date
September 30, 2012
Study Completion Date
March 31, 2013
AMG811
Twelve subjects will be randomized to receive AMG 811 in Period 1 and will receive AMG 811 Placebo in Period 2. The AMG 811 and AMG 811 Placebo will be administered by injection.
AMG811 Placebo
8 subjects will be randomized to receive AMG 811 Placebo in Period 1 and will receive AMG 811 in Period 2. The AMG 811 Placebo and AMG 811 will be administered by injection
Research Site, Philadelphia
Research Site, Durham
Research Site, Atlanta
Research Site, Ann Arbor
Research Site, Dallas
Research Site, Salt Lake City
Research Site, Santa Monica
Research Site, Stanford
Lead Sponsor
Amgen
INDUSTRY